Condition
Alzheimer's
Total Trials
5
Recruiting
1
Active
1
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 75/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
50% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (3)
P 2 (1)
P 3 (1)
Trial Status
Recruiting1
Terminated1
Completed1
Unknown1
Not Yet Recruiting1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07708675Not ApplicableNot Yet RecruitingPrimary
Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease - EU
NCT05655195Not ApplicableRecruiting
Chronic Treatment of Alzheimer's Disease by Gamma Light and Sound Therapy
NCT02260141Not ApplicableTerminatedPrimary
Treating Alzheimer's and Dementia With D-ribose
NCT03090516Phase 2UnknownPrimary
Clinical Efficacy of Ginkgo Biloba Extract in the Treatment of Alzheimer's Disease
NCT00209456Phase 3Completed
Dopamine Transporter Scintigraphy Imaging (DAT-Imaging) in Patients With Lewy Body Dementia
Showing all 5 trials